Oji Yusuke 尾路祐介

… Alternative Names

OJI Yusuke 尾路祐介

Less

Researcher Number	20294100
Other IDs
External Links
Affiliation (Current)	2025: 大阪大学, 大学院医学系研究科, 教授
Affiliation (based on the past Project Information) *help	2024: 大阪大学, 大学院医学系研究科, 教授 2022 – 2023: 大阪大学, 大学院医学系研究科, 教授 2020 – 2021: 大阪大学, 医学系研究科, 教授 2017: 大阪大学, 医学系研究科, 教授 2016: 大阪大学, 医学系研究科, 寄附講座教授 … More 2015: 大阪大学, 医学(系)研究科(研究院), 教授 2012 – 2014: 大阪大学, 医学(系)研究科(研究院), 寄附講座教授 2011: 大阪大学, 大学院医学系・研究科, 寄附講座教授 2010 – 2011: 大阪大学, 医学系研究科, 寄附講座教授 2009: Osaka University, 医学系研究科, 特任教授 2009: 大阪大学, 大学院・医学系研究科, 特任教授 2007 – 2008: Osaka University, Dept of Molecular Medicine, Associate Professor 2004 – 2006: 大阪大学, 医学系研究科, 助教授 2003: 大阪大学, 医学系研究科, 助手 1998 – 2002: Osaka University Medical School, Assistant Professor, 医学部, 助手 Less
Review Section/Research Field	Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related / Pathological medical chemistry / Pathological medical chemistry Except Principal Investigator Hematology / Biological Sciences / Hematology / Respiratory organ internal medicine
Keywords	Principal Investigator WT1 / solid cancer / 分子標的 / がん代謝 / 白血病 / leukemia / motility / WT1遺伝子 / 癌遺伝子 / 分子標的治療法 … More / 肺癌 / ウイルムス腫瘍遺伝子 / Lung cancer / 分子標的治療 / がん遺伝子 / anti-apootosis / プロテオミクス / 発がん遺伝子 / 浸潤能 / 抗アポトーシス / Leukemia / anti-apoptosis / WT1 gene / 代謝制御 / ゲノム安定性維持 / DNA repair / chemoresistance / oncogene / antiapoptosis / apoptosis / molecular targeted therapy / leukemogenesis / isoform / tumorigenesis … More Except Principal Investigator WT1 / 白血病 / leukemia / WT1遺伝子 / 免疫療法 / oncogene / leukemogenesis / minimal residual disease / 骨髄移植 / 微小残存白血病 / 造血幹細胞 / 癌ワクチン / Wilms' tumor gene / tumor suppressor gene / 骨髄異形成症候群 / WT1アッセイ / apoptosis / 微小残存病変 / MRD / immunotherany / myelochisplastic syndrome / Wilm's tumor gene / single-cell RT-PCR / 32D / tumor marker / cell cycle / M / G2 / CD34 / ウィルムス腫瘍遺伝子 / oncogenic / 白血病腫瘍マーカー / clinical trial / immunotherapy / 臨床試験 / bone marrow transplantation / キメラ遺伝子 / 微少残存腫瘍 / The WT1 gene / WWドメイン / アポトーシス / Leukemia / hematopoietic stem cell / WT1 gene / 微小残存腫瘍 / 癌免疫 / ペプチドワクチン / 癌免疫療法 / 肺癌 / 免疫学 / 癌 / 遺伝子 / 免役療法 / 分子標的治療法 / 分子標的治療 / 分子標的療法 / 分子診断 / 遺伝子診断 / WT1結合タンパク / ウイルムス腫瘍遺伝子 / 顆粒球系コロニー / Stat3 / 32D細胞 / G-CSF / MDS / AML / signal transduction / Leukemogenesis / real time PCR / WT1 assay Less

Metabolic network regulation by WT1 in hematopoietic malignanciesPrincipal Investigator
- Principal Investigator
  
  尾路祐介
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
WT1 controls metabolism in hematopoietic malignanciesPrincipal Investigator
- Principal Investigator
  
  Oji Yusuke
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Osaka University
A novel oncogenic function of Wilms tumor gene WT1 in leukemiaPrincipal Investigator
- Principal Investigator
  
  Oji Yusuke
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Oncogenic functions of the WT1 gene in leukemiaPrincipal Investigator
- Principal Investigator
  
  OJI Yusuke
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Antiapoptotic function of WT1 in leukemia and development of WT1-targeting molecular targeted therapyPrincipal Investigator
- Principal Investigator
  
  OJI
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Development of WT1 peptide cancer vaccine targeting lung cancer
- Principal Investigator
  
  OKA Yoshihiro
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Osaka University
Development of molecular diagnosis and molecule-targeted therapy for leukemia
- Principal Investigator
  
  SUGIYAMA Haruo
- Project Period (FY)
  2005 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
The function of the Wilms' tumor gene (WT1) overexpressed in leukemia and solid cancersPrincipal Investigator
- Principal Investigator
  
  OJI Yusuke
- Project Period (FY)
  2005 – 2006
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Osaka University
WT1 protein-targeted immunotherapy for leulemia
- Principal Investigator
  
  SUGIYAMA Haruo
- Project Period (FY)
  2003 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (S)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
WT1アッセイを用いた、白血病及び類縁疾患の遺伝子診断
- Principal Investigator
  
  杉山治夫
- Project Period (FY)
  2002 – 2004
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
肺癌細胞に過剰発現し、細胞増殖を促進するウィルムス腫瘍遺伝子の機能Principal Investigator
- Principal Investigator
  
  尾路祐介
- Project Period (FY)
  2002 – 2003
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Osaka University
Role of the Wilms' tumor gene WT1 in human leukemogenesis
- Principal Investigator
  
  SUGIYAMA Haruo
- Project Period (FY)
  2001 – 2002
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Immunotherapy against leukemia targeting WT1 product
- Principal Investigator
  
  OKA Yoshihiro
- Project Period (FY)
  2000 – 2001
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
白血病の原因遺伝子ろしてのWT1遺伝子の分子生物学的機能の解析
- Principal Investigator
  
  小川啓恭
- Project Period (FY)
  1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Osaka University
WT1アッセイを用いた、白血病と骨髄異形成症候群の治療の個別化
- Principal Investigator
  
  杉山治夫
- Project Period (FY)
  1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Osaka University
転写因子WT1の造血幹細胞の増殖,分化の制御に果たす役割の解析
- Principal Investigator
  
  杉山治夫
- Project Period (FY)
  1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
The role of the tumor suppressor gene WT1 in human leukemogenesis.
- Principal Investigator
  
  SUGIYAMA Haruo
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (B).
- Research Field
  
  Hematology
- Research Institution
  Osaka University
Oncogenic role of the Wilms' tumor gene in tumorigenesis of lung cancerPrincipal Investigator
- Principal Investigator
  
  OJI Yusuke
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Osaka University
Individualized therapy of patients with leukemia based on WT1 assay.
- Principal Investigator
  
  HIROYASU Ogawa
- Project Period (FY)
  1999 – 2000
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
白血病の遺伝子診断と白血病治療の個別化
- Principal Investigator
  
  SUGIYAMA Haruo
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Field
  
  Hematology
- Research Institution
  Osaka University
白血病の原因遺伝子としてのWT1遺伝子の分子生物学的機能の解析
- Principal Investigator
  
  小川啓恭
- Project Period (FY)
  1998
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Osaka University
WT1アッセイを用いた、白血病と骨髄異形成症候群の治療の個別化
- Principal Investigator
  
  杉山治夫
- Project Period (FY)
  1998
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Research Institution
  Osaka University
転写因子WT1の造血幹細胞の増殖、分化の制御に果たす役割の解析
- Principal Investigator
  
  杉山治夫
- Project Period (FY)
  1998
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas (A)
- Review Section
  
  Biological Sciences
- Research Institution
  Osaka University
Wilms tumor gene(WT1)expression in leukemic and normal hematopoietic stem cells.
- Principal Investigator
  
  OGAWA Hiroyasu
- Project Period (FY)
  1997 – 1998
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Osaka University

[Journal Article] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT12023
- Author(s)
  Oji Y, Kagawa N, Arita H, Naka N, Hamada KI, Outani H, Shintani Y, Takeda Y, Morii E, Shimazu K, Suzuki M, Nishida S, Nakata J, Tsuboi A, Iwai M, Hayashi S, Imanishi R, Ikejima S, Kanegae M, Iwamoto M, Ikeda M, Yagi K, Shimokado H, Nakajima H, Hasegawa K, Morimoto S, Fujiki F　他
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 2 Pages: 393-393
- DOI
  10.3390/cancers15020393
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07251, KAKENHI-PROJECT-19K08650, KAKENHI-PROJECT-20K08732, KAKENHI-PROJECT-22K09283, KAKENHI-PROJECT-23K06761, KAKENHI-PROJECT-19K09457
[Journal Article] WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies2018
- Author(s)
  Oji Y、Inoue M、Takeda Y、Hosen N、Shintani Y、Kawakami M、Harada T、Murakami Y、Iwai M、Fukuda M、Nishida S、Nakata J、Nakae Y、Takashima S、Shirakata T、Nakajima H、Hasegawa K、Kida H、Kijima T、Morimoto S、Fujiki F、Tsuboi A、Morii E、Morita S、Sakamoto J、Kumanogoh A、Oka Y、Okumura M、Sugiyama H
- Journal Title
  
  International Journal of Cancer
  
  Volume: 142 Issue: 11 Pages: 2375-2382
- DOI
  10.1002/ijc.31253
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09537, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476
[Journal Article] Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia2017
- Author(s)
  Anguille Sebastien、et al
- Journal Title
  
  Blood
  
  Volume: 130 Issue: 15 Pages: 1713-1721
- DOI
  10.1182/blood-2017-04-780155
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-15K09476
[Journal Article] Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.2017
- Author(s)
  Nakata J, Nakae Y, Kawakami M, Morimoto S, Motooka D, Hosen N, Fujiki F, Nakajima H, Hasegawa K, Nishida S, Tsuboi A, Oji Y, Oka Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Br J Haematol.
  
  Volume: XX Issue: 2 Pages: 287-290
- DOI
  10.1111/bjh.14768
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K19550
[Journal Article] Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.2016
- Author(s)
  Takashima S, Oka Y, Fujiki F, Morimoto S, Nakajima H, Nakae Y, Nakata J, Nishida S, Hosen N, Tatsumi N, Mizuguchi K, Hashimoto N, Oji Y, Tsuboi A, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Future Sci OA
  
  Volume: 2
- Data Source
  KAKENHI-PROJECT-15K09476
[Journal Article] A Zbtb7a proto-oncogene as a novel target for miR-125a.2016
- Author(s)
  Hojo N, Tatsumi N, Moriguchi N, Matsumura A, Morimoto S, Nakata J, Fujiki F, Nishida S, Nakajima H, Tsuboi A, Oka Y, Hosen N, Hayashi S, Sugiyama H, Oji Y.
- Journal Title
  
  Molecular Carcinogenesis
  
  Volume: - Issue: 12 Pages: 1-9
- DOI
  10.1002/mc.22446
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-25460685, KAKENHI-PROJECT-15K09476
[Journal Article] Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.2016
- Author(s)
  Oji Y, Hashimoto N, Tsuboi A, Murakami Y, Iwai M, Kagawa N, Chiba Y, Izumoto S, Elisseeva O, Ichinohasama R, Sakamoto J, Morita S, Nakajima H, Takashima S, Nakae Y, Nakata J, Kawakami M, Nishida S, Hosen N, Fujiki F, Morimoto S, Adachi M, Iwamoto M, Oka Y, Yoshimine T, Sugiyama H.
- Journal Title
  
  Int J Cancer.
  
  Volume: 139 Issue: 6 Pages: 1391-401
- DOI
  10.1002/ijc.30182
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25462257, KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-26462195, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-15K08609, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K10331, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-15K19550
[Journal Article] Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.2015
- Author(s)
  Tatsumi N, Hojo N, Sakamoto H, Inaba R, Moriguchi N, Matsuno K, Fukuda M, Matsumura A, Hayashi S, Morimoto S, Nakata J, Fujiki F, Nishida S, Nakajima H, Tsuboi A, Oka Y, Hosen N, Sugiyama H, Oji Y.
- Journal Title
  
  PLoS One
  
  Volume: 10 Issue: 6 Pages: e0130578-e0130578
- DOI
  10.1371/journal.pone.0130578
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-25460685
[Journal Article] Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.2015
- Author(s)
  Hashimoto N, Tsuboi A, Kagawa N, Chiba Y, Izumoto S, Kinoshita M, Kijima N, Oka Y, Morimoto S, Nakajima H, Morita S, Sakamoto J, Nishida S, Hosen N, Oji Y, Arita N, Yoshimine T, Sugiyama H.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: -
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] osen N, Sugiyama H, Oji Y.　 Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.2015
- Author(s)
  Tatsumi N, Hojo N, Yamada O, Ogawa M, Katsura Y, Kawata S, Morii E, Sakamoto H, Inaba R, Tsuda A, Fukuda I, Moriguchi N, Hasuwa H, Okabe M, Fujiki F, Nishida S, Nakajima H, Tsuboi A, Oka Y, Hosen N, Sugiyama H, Oji Y.
- Journal Title
  
  Oncogene
  
  Volume: 35 Issue: 8 Pages: 1003-14
- DOI
  10.1038/onc.2015.154
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-25460685
[Journal Article] Transduction of a Novel HLA-DRB1*04:05-restricted, WT1-specific TCR Gene into Human CD4+ T Cells Confers Killing Activity Against Human Leukemia Cells.2015
- Author(s)
  Katsuhara A, Fujiki F, Aoyama N, Tanii S, Morimoto S, Oka Y, Tsuboi A, Nakajima H, Kondo K, Tatsumi N, Nakata J, Nakae Y, Takashima S, Nishida S, Hosen N, Sogo S, Oji Y, Sugiyama H.
- Journal Title
  
  Anticancer Res
  
  Volume: 35 Pages: 1251-1261
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Wilms' tumor gene WT1 promotes homologous recombination- mediated DNA damage repair2015
- Author(s)
  Oji Y, Kobayashi J, et al.
- Journal Title
  
  Mol Carcinog
  
  Volume: in press Issue: 12 Pages: 1758-71
- DOI
  10.1002/mc.22248
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24310041, KAKENHI-PROJECT-24510063, KAKENHI-PROJECT-24591395, KAKENHI-PUBLICLY-25112513, KAKENHI-PROJECT-25460685, KAKENHI-PROJECT-26241013, KAKENHI-PROJECT-26550025, KAKENHI-PROJECT-15K09476
[Journal Article] Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.2015
- Author(s)
  Nakae Y, Oka Y, Fujiki F, Morimoto S, Kamiya T, Takashima S, Nakata J, Nishida S, Nakajima H, Hosen N, Tsuboi A, Kyo T, Oji Y, Mizuguchi K, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: -
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.2014
- Author(s)
  Andersson C, Oji Y, Ohlson N, Wang S, Li X, Ottander U, Lundin E, Sugiyama H, Li A.
- Journal Title
  
  Cancer Med.
  
  Volume: 印刷中
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers.2014
- Author(s)
  Oji Y, Tatsumi N, Fukuda M, Nakatsuka S, Aoyagi S, Hirata E, Nanchi I, Fujiki F, Nakajima H, Yamamoto Y, Shibata S, Nakamura M, Hasegawa K, Takagi S, Fukuda I, Hoshikawa T, Murakami Y, Mori M, Inoue M, Naka T, Tomonaga T, Shimizu Y, Nakagawa M, Hasegawa J, Nezu R, Inohara H, Izumoto S, Nonomura N, Yoshimine T, et al.
- Journal Title
  
  Int J Oncol.
  
  Volume: 44 Pages: 1461-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.2014
- Author(s)
  Kijima N, Hosen N, Kagawa N, Hashimoto N, Kinoshita M, Oji Y, Sugiyama H, Yoshimine T.
- Journal Title
  
  Anticancer Res.
  
  Volume: 34 Pages: 61-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.2014
- Author(s)
  Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K, Tsuboi A, Oka Y, Yanagisawa S, Toyama Y, Ikegami M, Kitagawa T, Eguchi H, Wada H, Nagano H, Nakata J, Nakae Y, Hosen N, Oji Y, Tanaka T, Kawase I, Kumanogoh A, Sakamoto J, Doki Y, Mori M, Ohkusa T, Tajiri H, Sugiyama H.
- Journal Title
  
  J Immunother.
  
  Volume: 37 Pages: 105-14
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers.2014
- Author(s)
  Oji Y, Tatsumni N, Izumoto S (34 名省略）
- Journal Title
  
  Int J Oncol
  
  Volume: 44 Issue: 5 Pages: 1461-1469
- DOI
  10.3892/ijo.2014.2318
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23592148, KAKENHI-PROJECT-24591395, KAKENHI-PROJECT-24700991, KAKENHI-PROJECT-25460685, KAKENHI-PROJECT-26462195
[Journal Article] Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.2014
- Author(s)
  Andersson C, Oji Y, Ohlson N, Wang S, Li X, Ottander U, Lundin E, Sugiyama H, Li A.
- Journal Title
  
  Cancer Med
  
  Volume: 3 Issue: 4 Pages: 909-918
- DOI
  10.1002/cam4.244
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model.2014
- Author(s)
  Yamanouchi K, Ohta T, Liu Z, Oji Y, Sugiyama H, Shridhar V, Matsumura S, Takahashi T, Takahashi K, Kurachi H.
- Journal Title
  
  Transl Oncol
  
  Volume: 24 Issue: 5 Pages: 580-589
- DOI
  10.1016/j.tranon.2014.07.008
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.2013
- Author(s)
  Nakata J, Nakano K, Okumura A, Mizutani Y, Kinoshita H, Iwai M, Hasegawa K, Morimoto S, Fujiki F, Tatsumi N, Nakajima H, Nakae Y, Nishida S, Tsuboi A, Oji Y, Oka Y, Sugiyama H, Kumanogoh A, Hosen N.
- Journal Title
  
  Leukemia.
  
  Volume: - Issue: 6 Pages: 1316-1325
- DOI
  10.1038/leu.2013.374
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395, KAKENHI-PROJECT-24700991, KAKENHI-PROJECT-25460685
[Journal Article] Functional human Th17 clones with WT1-specific helper activity.2013
- Author(s)
  Tachino S, Fujiki F, Oka Y, Tsuboi A, Morimoto S, Lin YH, Tamanaka T, Kondo K, Nakajima H, Nishida S, Hosen N, Oji Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 62 Pages: 801-10
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.2013
- Author(s)
  Lin Y, Fujiki F, Katsuhara A, Oka Y, Tsuboi A, Aoyama N, Tanii S, Nakajima H, Tatsumi N, Morimoto S, Tamanaka T, Tachino S, Hosen N, Nishida S, Oji Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  J Immunother.
  
  Volume: 36 Pages: 159-70
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.2013
- Author(s)
  Miyatake T, Ueda Y, Morimoto A, Enomoto T, Nishida S, Shirakata T, Oka Y, Tsuboi A, Oji Y, Hosen N, Nakatsuka S, Morita S, Sakamoto J, Sugiyama H, Kimura T.
- Journal Title
  
  J Cancer Res Clin Oncol.
  
  Volume: 139 Pages: 457-63
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine2013
- Author(s)
  Maeda T, Hosen N, Fukushima K, Tsuboi A, Morimoto S, Matsui T, Sata H, Fujita J, Hasegawa K, Nishida S, Nakata J, Nakae Y, Takashima S, Nakajima H, Fujiki F, Tatsumi N, Kondo T, Hino M, Oji Y, Oka Y, Kanakura Y, Kumanogoh A, Sugiyama H
- Journal Title
  
  Blood Cancer J
  
  Volume: 3 Issue: 8 Pages: e130-e130
- DOI
  10.1038/bcj.2013.29
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591423, KAKENHI-PROJECT-24591164, KAKENHI-PROJECT-24591395, KAKENHI-PROJECT-24700991, KAKENHI-PROJECT-25460685, KAKENHI-PROJECT-25461419, KAKENHI-PROJECT-25461450, KAKENHI-PROJECT-25830116
[Journal Article] Identification of a Wilms' tumor 1-derived immunogenic CD4(+) T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes.2013
- Author(s)
  Anguille S, Fujiki F, Smits EL, Oji Y, Lion E, Oka Y, Berneman ZN, Sugiyama H.
- Journal Title
  
  Leukemia.
  
  Volume: 27 Pages: 748-50
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] CD48 as a novel molecular target for antibody therapy in multiple myeloma2012
- Author(s)
  Hosen N, Ichihara H, Mugitani A, Aoyama Y, Fukuda Y, Kishida S, Matsuoka Y, Nakajima H, Kawakami M, Yamagami T, Fuji S, Tamaki H, Nakao T, Nishida S, Tsuboi A, Iida S, Hino M, Oka Y, Oji Y, Sugiyama H.
- Journal Title
  
  Br J Haematol
  
  Volume: 156 Issue: 2 Pages: 213-24
- DOI
  10.1111/j.1365-2141.2011.08941.x
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.2012
- Author(s)
  Tamanaka T, Oka Y, Fujiki F, Tsuboi A, Katsuhara A, Nakajima H, Hosen N, Nishida S, Lin YH, Tachino S, Akatsuka Y, Kuzushima K, Oji Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 5201-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Enhanced tumor immunity of WT1 peptide vaccination by interferon-βadministration2012
- Author(s)
  Nakajima H, Oka Y, Tsuboi A, Tatsumi N, Yamamoto Y, Fujiki F, Li Z, Murao A, Morimoto S, Hosen N, Shirakata T, Nishida S, Kawase I, Isaka Y, Oji Y, Sugiyama H.
- Journal Title
  
  Vaccine
  
  Volume: 30 Pages: 722-9
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22133512
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer2012
- Author(s)
  Hayashi S, Oji Y, Kanai Y, Teramoto T, Kitaichi M, Kawaguchi T, Okada M, Sugiyama H, Matsumura A.
- Journal Title
  
  Cancer Invest
  
  Volume: 30 Pages: 165-71
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22148937
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer2012
- Author(s)
  Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H, Sugiyama H.
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 1081-5
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22399636
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse : successful maintenance of durable remission2012
- Author(s)
  Hashii Y, Sato-Miyashita E, Matsumura R, Kusuki S, Yoshida H, Ohta H, Hosen N, Tsuboi A, Oji Y, Oka Y, Sugiyama H, Ozono K.
- Journal Title
  
  Leukemia
  
  Volume: 26 Issue: 3 Pages: 530-2
- DOI
  10.1038/leu.2011.226
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591205, KAKENHI-PROJECT-22591160
[Journal Article] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease.2012
- Author(s)
  Tsuboi A, Oka Y, Kyo T, Katayama Y, Elisseeva OA, Kawakami M, Nishida S, Morimoto S, Murao A, Nakajima H, Hosen N, Oji Y, Sugiyama H.
- Journal Title
  
  Leukemia
  
  Volume: 26 Pages: 1410-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.2012
- Author(s)
  Shirakata T, Oka Y, Nishida S, Hosen N, Tsuboi A, Oji Y, Murao A, Tanaka H, Nakatsuka S, Inohara H, Sugiyama H.
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 1081-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591395
[Journal Article] Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8^+ T cells in patients with solid tumors and healthy donors2012
- Author(s)
  Morimoto S., et al
- Journal Title
  
  Cancer Science
  
  Volume: 103 Issue: 3 Pages: 408-414
- DOI
  10.1111/j.1349-7006.2011.02163.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590991, KAKENHI-PROJECT-21591205, KAKENHI-PROJECT-21591870, KAKENHI-PUBLICLY-22103508, KAKENHI-PROJECT-22700896, KAKENHI-PROJECT-23390364, KAKENHI-PROJECT-23592123, KAKENHI-PROJECT-23592148, KAKENHI-PROJECT-24592160
[Journal Article] CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients2012
- Author(s)
  Hosen N, Matsuoka Y, Kishida S, Nakata J, Mizutani Y, Hasegawa K, Mugitani A, Ichihara H, Aoyama Y, Nishida S, Tsuboi A, Fujiki F, Tatsumi N, Nakajima H, Hino M, Kimura T, Yata K, Abe M, Oka Y, Oji Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Leukemia
  
  Volume: (in press) Issue: 9 Pages: 2135-2141
- DOI
  10.1038/leu.2012.80
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591205, KAKENHI-PUBLICLY-23130509, KAKENHI-PROJECT-23591386, KAKENHI-PROJECT-23591390, KAKENHI-PROJECT-23790622
[Journal Article] Use of(11) C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma2012
- Author(s)
  Chiba Y, Kinoshita M, Okita Y, Tsuboi A, Isohashi K, Kagawa N, Fujimoto Y, Oji Y, Oka Y, Shimosegawa E, Morita S, Hatazawa J, Sugiyama H, Hashimoto N, Yoshimine T.
- Journal Title
  
  J Neurosurg
  
  Volume: 116 Pages: 835-42
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22242671
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease2011
- Author(s)
  Tsuboi A, Oka Y, Kyo T, Katayama Y, Elisseeva OA, Kawakami M, Nishida S, Morimoto S, Murao A, Nakajima H, Hosen N, Oji Y, Sugiyama H.
- Journal Title
  
  Leukemia
  
  Volume: 2011(in press) Issue: 6 Pages: 1410-1413
- DOI
  10.1038/leu.2011.343
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591205, KAKENHI-PROJECT-21591870, KAKENHI-PROJECT-24591164
[Journal Article] Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination2010
- Author(s)
  Van Tendeloo VF, Van de Velde A, Van Driessche A, Cools N, Anguille S, Ladell K, Gostick E, Vermeulen K, Pieters K, Nijs G, Stein B, Smits EL, Schroyens WA, Gadisseur AP, Vrelust I, Jorens PG, Goossens H, de Vries IJ, Price DA, Oji Y, Oka Y, Sugiyama H, B
- Journal Title
  
  Proc Natl Acad Sci USA
  
  Volume: 107 Pages: 13824-9
- URL
  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922237/?tool=pubmed
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow (BM) in tumor-bearing patients: an important role of BM as a secondary lymphoid organ.2010
- Author(s)
  Murao A, Oka Y, Tsuboi A, Elisseeva OA, Harada Y, Fujiki F, Nakajima H, Nishida S, Hosen N, Shirakata T, Hashimoto N, Myoui A, Ueda T, Takeda Y, Osaki T, Enomoto T, Yoshikawa H, Kimura T, Oji Y, Kawase I, Sugiyama H.
- Journal Title
  
  Cancer Science (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Prognostic Significance of WT1 mRNA and anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.2010
- Author(s)
  Tamura H, Dan K, Yokose N, Iwakiri R, Ohta M, Sakamaki H, Tohyama K, Kondo A, Hyodo H, Nakamura K, Yamashita T, Elisseeva O. A, Oka Y, Oji Y, Sugiyama H, Ogata K.
- Journal Title
  
  Leukemia Research (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Biased usage of BV gene families of T cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies2010
- Author(s)
  Tanaka-Harada Y, Kawakami M, Oka Y, Tsuboi A, Katagiri T, Elisseeva O, Nishida S, Shirakata T, Hosen N, Fujiki F, Murao A, Nakajima H, Oji Y, Kanda Y, Kawase I, Sugiyama H.
- Journal Title
  
  Cancer Science 101
  
  Pages: 594-600
- NAID
  10026589035
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination2010
- Author(s)
  Fujiki F, Oka Y, Kawakatsu M, Tsuboi A, Tanaka-Harada Y, Hosen N, Nishida S, Shirakata T, Nakajima H, Tatsumi N, Hashimoto N, Taguchi T, Ueda S, Nonomura N, Takeda Y, Ito T, Myoui A, Izumoto S, Maruno M, Yoshimine T, Noguchi S, Okuyama A, Kawase I, Oji Y,
- Journal Title
  
  Anticancer Res
  
  Volume: 30 Pages: 2247-54
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/20651376
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Prognostic significance of WT1 mRNA and anti-WT1 antibody levels inperipheral blood in patients with myelodysplastic syndromes2010
- Author(s)
  Tamura H, Dan K, Yokose N, Iwakiri R, Ohta M, Sakamaki H, Tohyama K, KondoA, Hyodo H, Nakamura K, Yamashita T, Elisseeva OA, Oka Y, Oji Y, Sugiyama H, Ogata K.
- Journal Title
  
  Leuk Res
  
  Volume: 34 Pages: 986-90
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/20031209
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient2010
- Author(s)
  Oji Y, Oka Y, Nishida S, Tsuboi A, Kawakami M, Shirakata T, Takahashi K, Murao A, Nakajima H, Narita M, Takahashi M, Morita S, Sakamoto J, Tanaka T, Kawase I, Hosen N, Sugiyama H.
- Journal Title
  
  Eur J Haematol
  
  Volume: 85(4) Issue: 4 Pages: 358-60
- DOI
  10.1111/j.1600-0609.2010.01497.x
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Biased usage of BV gene families of T-cell receptors of WT1(Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies2010
- Author(s)
  Tanaka-Harada Y, Kawakami M, Oka Y, Tsuboi A, Katagiri T, Elisseeva OA, Nishida S, Shirakata T, Hosen N, Fujiki F, Murao A, Nakajima H, Oji Y, Kanda Y, Kawase I, Sugiyama H.
- Journal Title
  
  Cancer Sci
  
  Volume: 101 Pages: 594-600
- NAID
  10026589035
- URL
  http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2009.01453.x/abstract
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide2010
- Author(s)
  Ichinohasama R, Oji Y, Yokoyama H, Takeuchi K, Fujiwara T, Ishizawa K, Taniguchi O, Tsuboi A, Oka Y, Sugiyama H.
- Journal Title
  
  Cancer Sci
  
  Volume: 101 Pages: 1089-92
- NAID
  10026591723
- URL
  http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2010.01522.x/abstract;jsessionid=8A19D28E675DF64AEAAAC58923BDEE88.d02t03
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients : an important role of bone marrow as a secondary lymphoid organ2010
- Author(s)
  Murao A, Oka Y, Tsuboi A, Elisseeva OA, Tanaka-Harada Y, Fujiki F, Nakajima H, Nishida S, Hosen N, Shirakata T, Hashimoto N, Myoui A, Ueda T, Takeda Y, Osaki T, Enomoto T, Yoshikawa H, Kimura T, Oji Y, Kawase I, Sugiyama H.
- Journal Title
  
  Cancer Sci
  
  Volume: 101 Pages: 848-54
- NAID
  10026590478
- URL
  http://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2009.01468.x/abstract
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways2010
- Author(s)
  Sitaram RT, Degerman S, Ljungberg B, Andersson E, Oji Y, Sugiyama H, Roos G, Li A.
- Journal Title
  
  Br J Cancer
  
  Volume: 103 Pages: 1255-62
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/20842112
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor2009
- Author(s)
  Oji Y, et al.
- Journal Title
  
  Int J Cancer 125
  
  Pages: 381-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591205
[Journal Article] WT1 (Wilms' tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma : a case report2009
- Author(s)
  Ohta H., Hashii Y., Oka Y., Oji Y., Ozono K. et al (岡芳弘 : 15人中10番目、尾路祐介 : 15人中11番目)
- Journal Title
  
  Pediatric Hematology and Oncology 26
  
  Pages: 74-83
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] WT1 IgG antibody for early detection of non-small cell lung cancer and as its prognostic factor.2009
- Author(s)
  Oji Y., et al
- Journal Title
  
  International Journal of Cancer in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors2008
- Author(s)
  Tatsumi N., Oji Y., Tsuji N., Oka Y., Sugiyama H. et al (岡芳弘 : 19人中18番目、尾路祐介 : 19人中2番目)
- Journal Title
  
  International Journal of oncology 32
  
  Pages: 707-711
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] "Cancer antigen WT1 protein-derived peptide"-based treatment of cancer-Toward the further development-2008
- Author(s)
  Oka Y., Tsuboi A., Fujiki F., Shirakata T., Oji Y. et al (岡芳弘 : 11人中1番目、尾路祐介 : 11人中10番目)
- Journal Title
  
  Current Medicinal Chemistry 15
  
  Pages: 3052-3061
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] A WT1 protein-derived, naturally processed 16-mer peptide, WT1332, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4+ T cells.2008
- Author(s)
  Fujiki F, Oka Y, Kawakatsu M, Tsuboi A, Nakajima H, Elisseeva OA, Harada Y, Li Z, Tatsumi N, Kamino E, Shirakata T, Nishida S, Taniguchi Y, Kawase I, Oji Y, Sugiyama H.
- Journal Title
  
  Microbiol Immunol 52
  
  Pages: 591-600
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Phase II clinical trial of WT1(Wilms tumor gene) peptide vaccination for patients with recurrent glioblastoma2008
- Author(s)
  Izumoto S., Tsuboi A., Oka Y., Oji Y., et al (岡芳弘 : 22人中3番目、尾路祐介 : 22人中12番目)
- Journal Title
  
  Journal of Neurosurgery 108
  
  Pages: 963-971
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] WT1 peptide vaccine for the treatment of cancer2008
- Author(s)
  Oka Y., Tsuboi A., Oji Y., Kawase I., Sugiyama H.
- Journal Title
  
  Current Opinion in Immunology 20
  
  Pages: 211-220
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] Identification of a WT1 protein-derived peptide, WT1187 as an HLA-A*0206-restricted WT1-specific CTL epitope2008
- Author(s)
  Li Z., Oka Y., Tsuboi A., Oji Y. et al (岡芳弘 : 20人中2番目、尾路祐介 : 20人中19番目)
- Journal Title
  
  Microbiology and Immunology 52
  
  Pages: 551-558
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] A WT1 protein-derived, naturally processed 16-mer peptide, WT1332, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4+ T cells2008
- Author(s)
  Fujiki F., Oka Y., Kawakatsu M., Oji Y. et al(岡芳弘 : 16人中2番目、尾路祐介 : 16人中15番目)
- Journal Title
  
  Microbiology and Immunology 52
  
  Pages: 591-600
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] Identification of a WT1 protein-derived peptide, WT1187 as an HLA-A*0206-restricted, WT1-specific CTL epitope" is currently at the following stage of production.2008
- Author(s)
  Li Z, Oka Y, Tsuboi A, Fujiki F, Harada Y, Nakajima H, Masuda T, Fukuda Y, Kawakatsu M, Morimoto S, Katagiri T, Tatsumi N, Hosen N, Shirakata T, Nishida S, Kawakami Y, Udaka K, Kawase I, Oji Y, Sugiyama H.
- Journal Title
  
  Microbiol Immunol 52
  
  Pages: 551-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 mug/body) in a patient with chronic myelomonocytic leukemia.2007
- Author(s)
  Kawakami M, Oka Y, Tsuboi A, Harada Y, Elisseeva OA, Furukawa Y, Tsukaguchi M, Shirakata T, Nishida S, Nakajima H, Morita S, Sakamoto J, Kawase I, Oji Y, Sugiyama H.
- Journal Title
  
  Int J Hematol 85
  
  Pages: 426-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Wilms' tumor geneWT1 peptide-based immunotherapy induced minimal response in a patient with advanced, therapy-resistant multiple myeloma2007
- Author(s)
  Tsuboi A., Oka Y., Nakajima H. Oji Y. et al (岡芳弘 : 21人中2番目、尾路祐介 : 21人中15番目)
- Journal Title
  
  International Journal of Hematology 86
  
  Pages: 414-417
- NAID
  10019533221
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Journal Article] Identification and characterization of a WT1 (Wilms' tumor gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes.2007
- Author(s)
  Fujiki F, Oka Y, Tsuboi A, Kawakami M, Nakajima H, Elisseeva OA, Harada Y, Ito K, Li Z, Tatsumi N, Sakaguchi N, Fujioka T, Masuda T, Yasukawa M, Udaka K, Oji Y, Sugiyama H.
- Journal Title
  
  J Immunother 30
  
  Pages: 282-93
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] A phase I/II trial of a WT1 (Wilms' Tumor Gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data.2006
- Author(s)
  Morita S, Oka Y., Tsuboi A, Kawakami M, Maruno M, Izumoto S, Osaki T, Taguchi T, Ueda T, Myoui A, Nishida S, Shirakata T, Ohno S, Oji Y, Aozasa K, Hatazawa J, Udaka K, Yoshikawa H, Yoshimine T, Noguchi S, Kawase I, Nakatsuka S, Sugiyama H, Sakamoto J.
- Journal Title
  
  Japanese Journal of Clinical Oncology 36
  
  Pages: 231-236
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] WT1(235), a ninemer peptide derived from Wilms' tumor gene product, is a candidate peptide for the vaccination of HLA-A*0201-positive patients with hematopoietic malignancies.2005
- Author(s)
  Li Z, Oka Y, Tsuboi A, Masuda T, Tatsumi N, Kawakami M, Fujioka T, Sakaguchi N, Nakajima H, Fujiki F, Udaka K, Oji Y, Kawase I, Sugiyama H.
- Journal Title
  
  Int J Hematol 82
  
  Pages: 458-459
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.2005
- Author(s)
  Wu F, Oka Y, Tsuboi A, Elisseeva O. A, Nakajima H, Fujiki F, Masuda T, Murakami M, Yoshihara S, Ikegame K, Hosen N, Kawakami M, Nakagawa M, Kubota T, Soma T, Yamagami T, Tsukaguchi M, Ogawa H, Oji Y, Hamaoka T, Kawase I, Sugiyama H.
- Journal Title
  
  Leukemia 19
  
  Pages: 268-274
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17015028
[Journal Article] Anti-apoptotic function of 17AA(+)WT1 isoforms on the intrinsic apoptosis pathway
- Author(s)
  Ito K., Oji Y., Tatsumi N., et al.
- Journal Title
  
  Oncogene (In press)
- Data Source
  KAKENHI-PROJECT-17590266
[Journal Article] Wilms' Tumor Gene WT1 17AA(-)/KTS(-) Isoform Induces Morphological Changes and Promotes Cell Migration and Invasion in vitro.
- Author(s)
  Jomgeow T, Oji Y, Tsuji N, et al.
- Journal Title
  
  Cancer Science (In press)
- NAID
  10017985844
- Data Source
  KAKENHI-PROJECT-17590266
[Journal Article] WT1 IgG antibody for early detection of non-small cell lung cancer and as its prognostic factor
- Author(s)
  Oji Y., Kitamura Y., Kamino E., Kitano A., Oka Y., Kawase I., et.al. (岡芳弘 : 27人中22番目、尾路祐介 : 27人中1番目)
- Journal Title
  
  International Journal of Cancer (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] 薬効評価のための簡便な2ステップ-スフェロイド培養法2022
- Author(s)
  岩出拓也　西井綾乃　加藤千晶　尾路祐介
- Organizer
  第81回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20K08732
[Presentation] Standardization of WT1 Immunohistochemical Staining and Evaluation of WT1 Positivity in Solid Cancers2011
- Author(s)
  Oji Y, Berneman Z. N, Keilholz U, O' reilly R, Saglio G, Wagner N, Heike Y, Lundin E, Aozasa K, Pauwels P, Anguille S, Cilloni D, Ohashi H, Waelput W, Fukuda M, Tatsumi N, Oka Y, Sugiyama H.
- Place of Presentation
  Turin, Italy
- Year and Date
  2011-04-15
- Data Source
  KAKENHI-PROJECT-21591205
[Presentation] WT1 Expression in Tumor Endothelial Cells2010
- Author(s)
  Fukuda M, Oji Y, Nakatsuka S, Oka Y, Tsuboi A, Hosen N, Nishida S, Tatsumi N, Aozasa K, Sugiyama K.
- Organizer
  第69回日本癌学会学術集会
- Place of Presentation
  大阪
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-21591205
[Presentation] グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法2009
- Author(s)
  尾路祐介、岡芳弘、西田純幸、白方俊章、保仙直毅、坪井昭博、中島博子、村尾綾子、杉山治夫
- Organizer
  第71回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2009-10-25
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1 IgG抗体は非小細胞肺癌の早期診断と予後診断に有用なマーカーである2009
- Author(s)
  北野愛子、尾路祐介、中村三千代、岡芳弘ら(岡芳弘 : 9人中2番目、尾路祐介 : 9人中7番目)
- Organizer
  第日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2009-10-29
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] MDSに対するWT1ワクチン療法2009
- Author(s)
  坪井昭博、岡芳弘、川上学、尾路祐介、保仙直毅、西田純幸、米谷昇、杉山治夫
- Organizer
  第71回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] 骨髄異形成症候群における末梢血WT1mRNA発現と抗WT1抗体産生の臨床的意義2009
- Author(s)
  田村秀人、緒方清行、横瀬紀夫、岩切理歌、大田雅嗣、坂巻壽、遠山薫、山下泰史、近藤麻加、兵働英也、中村恭子、尾路祐介、杉山治夫、壇和夫
- Organizer
  第71回日本血液学会学術集会
- Place of Presentation
  京都
- Year and Date
  2009-10-24
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] 大腸癌、膵癌に対するWT1ペプチドワクチン療法2008
- Author(s)
  岡芳弘、西田純幸、武田裕、尾路祐介ら(岡芳弘 : 10人中1番目、尾路祐介 : 10人中5番目)
- Organizer
  第21回日本バイオセラピィ学会学術集会総会
- Place of Presentation
  東京
- Year and Date
  2008-11-19
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] 進行大腸癌に対するHLA-A*2402拘束性WT1ワクチン療法第I/II相臨床試験2008
- Author(s)
  西田純幸、岡芳弘、坪井昭博、尾路祐介ら(岡芳弘 : 10人中2番目、尾路祐介 : 10人中5番目)
- Organizer
  第日本癌学会学術総会
- Place of Presentation
  名古屋
- Year and Date
  2008-10-30
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法2008
- Author(s)
  尾路祐介、岡芳弘、西田純幸、白方俊章ら(岡芳弘 : 10人中2番目、尾路祐介 : 10人中1番目)
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Year and Date
  2008-10-10
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] MDS-AMLに対しHLA-A*2402拘束性改変型WT1ペプチドワクチン療法を行い、長期間AMLの再発なく経過している1例2008
- Author(s)
  西田純幸、川上学、坪井昭博、村尾綾子、宮井沙緒里、白方俊章、保仙直毅、尾路祐介、塚口真知子、岡芳弘、杉山治夫
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Year and Date
  2008-10-11
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法2008
- Author(s)
  尾路祐介、白方俊章、岡芳弘、西田純幸、坪井昭博、保仙直毅、杉山治夫
- Organizer
  第89回近畿血液学地方会
- Place of Presentation
  大阪
- Year and Date
  2008-06-21
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] MDS-AMLに対しHLA-A*2402拘束性改変型WT1ペプチドワクチン療法を行い、長期間AMLの再発なく経過している1例2008
- Author(s)
  西田純幸、川上学、坪井昭博、村尾綾子、尾路祐介、岡芳弘ら(岡芳弘 : 11人中10番目、尾路祐介 : 11人中8番目)
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Year and Date
  2008-10-11
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法2008
- Author(s)
  尾路祐介ら
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都市
- Year and Date
  2008-10-10
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法2008
- Author(s)
  尾路祐介、岡芳弘、西田純幸、白方俊章、保仙直毅、高橋和子、村尾綾子、中島博子、坪井昭博、杉山治夫
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Year and Date
  2008-10-10
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] MRDを有する再発高リスク急性骨髄性白血病患者にWT1ワクチン療法行い5年以上の寛解を維持している3症例2008
- Author(s)
  坪井昭博、岡芳弘、西田純幸、尾路祐介ら(岡芳弘 : 9人中2番目、尾路祐介 : 9人中6番目)
- Organizer
  第70回日本血液学会総会
- Place of Presentation
  京都
- Year and Date
  2008-10-11
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] shRNA targeting WT1 17AA(+) isoforms is a potent apotosis-inducing agent for solid tumors2007
- Author(s)
  辰巳直也、尾路祐介、東尾麻里、岡芳弘ら(尾路祐介 : 9人中2番目、岡芳弘 : 9人中8番目)
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-03
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] Co-administration of WT1 peptide vaccine and IFN-・enhances tumor rejection compared to the injection of WT1 peptide vaccine alone in a mouse model.2007
- Author(s)
  Nakajima H, Oka Y, Tsuboi A, Oji Y, Sugiyama H.
- Organizer
  3rd International Conference on WT1 in Human Malignancies
- Place of Presentation
  Berlin
- Year and Date
  2007-09-19
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1ペプチドワクチン療法により長期に血液学的寛解を維持しているAML3症例2007
- Author(s)
  岡芳弘、坪井昭博、尾路祐介、川瀬一郎ら(岡芳弘 : 15人中1番目、尾路祐介 : 15人中13番目)
- Organizer
  第69回日本血液学会/第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] リアルタイムPCRを用いた担癌患者末梢血中のWT1特異的CD4陽性T細胞の定量的解析2007
- Author(s)
  藤木文博、岡芳弘、川勝真衣、尾路祐介ら(岡芳弘 : 12人中2番目、尾路祐介 : 12人中11番目)
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] WT1 peptide vaccination at very low-dose for myelodysplastic syndrome.2007
- Author(s)
  Kawakami M, Oka Y, Tsuboi A, Harada Y, Elisseeva OA, Furukawa Y, Hayashi T, Nishida S, Shirakata T; Hosen N, Nakajima H, Yamagami T, Soma T, Oji Y, Sugiyama H.
- Organizer
  3rd International Conference on WT1 in Human Malignancies
- Place of Presentation
  Berlin
- Year and Date
  2007-09-19
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] Production of anti-Wilms tumor gene WT1 IgG antibody in patients with non small lung cancer (NSCLC)2007
- Author(s)
  尾路祐介、北村弥生、上農枝里子、北野愛子、岡芳弘、三好新一郎、杉山治夫
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-03
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] 顎下腺患者に対するWT1ペプチド癌ワクチン療法2007
- Author(s)
  白方俊章、猪原秀典、岡芳弘、尾路祐介、久保武ら(岡芳弘 : 11人中3番目、尾路祐介 : 11人中7番目)
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] 多発性骨髄腫に対してWT1ペプチドワクチンを行って有効であった一例2007
- Author(s)
  坪井昭博、岡芳弘、西田純幸、白方俊章、尾路祐介、杉山治夫
- Organizer
  第69回日本血液学会/第49回日本臨床血液学会合同総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-12
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] Single cell RT-PCR法を用いた、WT1ワクチン投与患者体内でのWT1特異的CTLクローンの動態解析2007
- Author(s)
  原田ゆきえ、岡芳弘、川上学、尾路祐介ら(岡芳弘 : 13人中2番目、尾路祐介 : 13人中11番目)
- Organizer
  第66回日本癌学会学術総会
- Place of Presentation
  横浜
- Year and Date
  2007-10-04
- Data Source
  KAKENHI-PROJECT-19590894
[Presentation] 分子再発後にWT1ワクチンを投与し長期寛解を維持している急性骨髄性白血病の3例2006
- Author(s)
  尾路祐介, 坪井昭博, 西田純幸, 白方俊章, 杉山治夫, 岡芳弘, 川上学
- Organizer
  第86回近畿血液学地方会
- Place of Presentation
  和歌山
- Year and Date
  2006-11-18
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] 骨髄異形成症候群(MDS)に対する少量WT1ペプチド療法2006
- Author(s)
  川上学、坪井昭博、西田純幸、白方俊章、原田ゆきえ、中島博子、藤木文博、李哲雨、OLGA ELISSEEVA、尾路祐介、古川佳央、林孝昌、岡芳弘、杉山治夫
- Organizer
  第68回日本血液学会総会・第48回日本臨床血液学会総会合同総会
- Place of Presentation
  福岡
- Year and Date
  2006-10-07
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1ペプチド癌ワクチン投与患者末梢血中のWT1特異的CTLの解析2006
- Author(s)
  岡芳弘、OLGA ELISSEEBA、長谷浩志、川上学、西田純幸、白方俊章、原田ゆきえ、中島博子、李哲雨、藤木文博、尾路祐介、川瀬一郎、坪井昭博、杉山治夫
- Organizer
  第68回日本血液学会総会・第48回日本臨床血液学会総会合同総会
- Place of Presentation
  福岡
- Year and Date
  2006-10-07
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1(Wilms' tumor gene) peptide-based immunotherapy for myelodysplastic syndrome2005
- Author(s)
  Haruo Sugiyama, Akihiro Tsuboi, Manabu Kawakami Yusuke Oji, Yoshihiro Oka
- Organizer
  8th International Symposium on Myelodysplastic Syndromes MDS 2005
- Place of Presentation
  長崎
- Year and Date
  2005-05-14
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1 specific CTLs in WT1 peptide vaccine-treated patients2005
- Author(s)
  Olga Elisseeva, Yoshihiro Oka, Akihiro Tsuboi, Hiroshi Hase, Hiroko Nakajima, Yukie Harada, Manabu Kawakami, Fumihiro Fujiki, Sumiyuki Nishida, Toshiaki Shirakata, Satoshi Oono, Ichirou Kawase, Yusuke Oji, Haruo Sugiyama
- Organizer
  The Second International Conference on WT1 in Human Neoplasia
- Place of Presentation
  Kyoto
- Year and Date
  2005-10-22
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] Identification and characterization of a WT1 (Wilms' tumor gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes2005
- Author(s)
  Fumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, Manabu Kawakami, Mai Kawakatsu, Hiroko Nakajima, Olga A. Elisseeva, Yukie Harada, Ken Ito, Zheyu Li, Naoya Tatsumi, Nao Sakaguchi, Tatsuya Fujioka, Tomoki Masuda, Masaki Yasukawa, Keiko Udaka, Yusuke Oji, Haruo Sugiyama
- Organizer
  The Second International Conference on WT1 in Human Neoplasia
- Place of Presentation
  Kyoto
- Year and Date
  2005-10-21
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] 少量WT1ペプチド療法により慢性骨髄単球性白血病(CMML)の進行が抑制された1例2005
- Author(s)
  川上学, 坪井昭博, 西田純幸, 白方俊章, 岡芳弘, 尾路祐介, 杉山治夫, 古川佳央
- Organizer
  第83回近畿血液学地方会
- Place of Presentation
  大阪
- Year and Date
  2005-06-11
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] 骨髄異形成症候群(MDS)に対する少量WT1ペプチド療法2005
- Author(s)
  川上学, 坪井昭博、原田ゆきえ, 中島博子, 白方俊章, 大野智, 藤木文博, 李哲雨, エリセーバ・オリガ, 尾路祐介, 古川佳央, 岡芳弘, 杉山治夫
- Organizer
  第9回基盤的癌免疫研究会総会
- Place of Presentation
  東京
- Year and Date
  2005-07-15
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1ペプチドワクチン療法が奏効した多発性骨髄腫の1例2005
- Author(s)
  坪井昭博, 川上学, 西田純幸, 中島博子, 岡芳弘, 白方俊章, 大野智, 尾路祐介, 杉山治夫
- Organizer
  第83回近畿血液学地方会
- Place of Presentation
  大阪
- Year and Date
  2005-06-11
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1特異的CD4*ヘルパーT細胞を誘導できるHLA-classII拘束性ペプチドの同定2005
- Author(s)
  藤木文博, 岡芳弘, 坪井昭博, 川上学, 川勝真衣, 中島博子, オリガ・エリセーバ, 原田ゆきえ, 李哲雨, 伊藤憲, 宇高恵子, 尾路祐介, 杉山治夫
- Organizer
  第64回日本癌学会学術総会
- Place of Presentation
  札幌
- Year and Date
  2005-09-16
- Data Source
  KAKENHI-PROJECT-17015028
[Presentation] WT1-peptide vaccination for acute myeloid leukemia2005
- Author(s)
  Manabu Kawakami, Yoshihiro Oka, Akihiro Tsuboi, Hiroko Nakajima, Olga A. Elisseeva, Hiroshi Hase, Yukie Harada, Fumihiro Fujiki, Zheyu LI, Tatsumi, Sumiyuki Nishida, Satoshi Ohno, Toshiaki Shirakata, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
- Organizer
  The Second International Conference on WT1 in Human Neoplasia
- Place of Presentation
  Kyoto
- Year and Date
  2005-10-22
- Data Source
  KAKENHI-PROJECT-17015028

1. OKA Yoshihiro (20273691)

# of Collaborated Projects: 17 results

# of Collaborated Products: 50 results
2. SUGIYAMA Haruo (70162906)

# of Collaborated Projects: 11 results

# of Collaborated Products: 29 results
3. SOMA Toshihiro (40273619)

# of Collaborated Projects: 10 results

# of Collaborated Products: 0 results
4. OGAWA Hiroyasu (80194447)

# of Collaborated Projects: 10 results

# of Collaborated Products: 0 results
5. TATEKAWA Toyoshi

# of Collaborated Projects: 4 results

# of Collaborated Products: 0 results
6. TSUBOI Akihiro

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
7. HOSEN Naoki (10456923)

# of Collaborated Projects: 1 results

# of Collaborated Products: 10 results
8. FUJIKI Fumihiro (40456926)

# of Collaborated Projects: 1 results

# of Collaborated Products: 15 results
9. OSAKI TADASHI (50324778)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. TAKEDA YOSHITO (40452388)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 三宅正剛 (60294097)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. MENSSEN H.D.

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. MARGOLIS Dav

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 川上学

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. AKIHIRO Tsuboi

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. IZUMOTO Shuichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. NISHIDA Sumiyuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
18. Morimoto Soyoko

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
19. KIDA Hiroshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
20. CHIBA Yasuyoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
21. 小林純也

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 井上義一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. 日野雅之

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 橋本直哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Oji Yusuke 尾路 祐介

OJI Yusuke 尾路 祐介

Research Projects

Research Products

Co-Researchers

Metabolic network regulation by WT1 in hematopoietic malignanciesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

WT1 controls metabolism in hematopoietic malignanciesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A novel oncogenic function of Wilms tumor gene WT1 in leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Oncogenic functions of the WT1 gene in leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Antiapoptotic function of WT1 in leukemia and development of WT1-targeting molecular targeted therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The function of the Wilms' tumor gene (WT1) overexpressed in leukemia and solid cancersPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肺癌細胞に過剰発現し、細胞増殖を促進するウィルムス腫瘍遺伝子の機能Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Oji Yusuke 尾路祐介

OJI Yusuke 尾路祐介